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A B S T R A C T
Background: Patients with acute myocardial infarction (AMI) are at high risk for
reinfarction and death. Therapies that have been shown to reduce these risks (secondary
prevention) continue to be underutilized. Nurse practitioners are well positioned to
provide secondary prevention during and following hospitalization.
Objectives: The purpose of this study was to evaluate the effects of NP care on the rate of
provider implementation and patient achievement of evidence-based secondary
prevention target goals.
Design: A prospective cohort design was used, which compared achievement of target
goals between patients who received secondary prevention care from an NP to those who
received usual care.
Participants: The sample consisted of 65 patients with AMI, admitted to a large
community hospital. Patients meeting eligibility criteria were recruited consecutively.
Methods: The intervention was delivered by the NP before discharge from hospital and
one week, two weeks, six weeks and 3 months after discharge. Data on patients’
achievement of goals were obtained before discharge from hospital and 3 months after
discharge from both groups.
Results: This study’s results provide preliminary evidence that an NP delivered secondary
prevention intervention can signiﬁcantly improve achievement of the following target
goals when compared to usual care: smoking cessation (OR 5), blood pressure (OR 15),
attendance at cardiac rehabilitation (OR 7), physical activity ﬁve days a week (OR 17),
physical activity  ﬁve days a week (OR 34), achieving a glycated haemoglobin < 7% in
those with diabetes (OR 10), triglyceride levels (p = .02), statin use at follow-up (p = .05),
and number of weeks to cardiac rehabilitation (p = .05).
Conclusion: NP-led interventions such as this warrant duplication to evaluate reproduc-
ibility of the intervention and to determine if short-term improvements in secondary
prevention goals translate into morbidity and mortality beneﬁts.
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P. Harbman / International Journal of Nursing Studies 51 (2014) 1542–1556 1543 Secondary prevention programmes, with and without
exercise components, improve outcomes in patients
following acute myocardial infarction (Clark et al., 2005).
 Cardiac rehabilitation programmes, the most typical
form of secondary prevention programme, are utilized by
less than 30% of those eligible.
What this paper adds
 The results of this study demonstrate that a nurse
practitioner can safely and effectively deliver a compre-
hensive secondary prevention intervention.
 A nurse practitioner delivered secondary prevention
intervention is well received by patients and signiﬁcant-
ly improves the implementation of guideline based
secondary prevention treatments and risk factor reduc-
tion strategies, and improves treatment goals achieved
by patients.
 Diabetes and activity levels, risk factors that have been
challenging to improve in most secondary preventions
programmes, were signiﬁcantly improved with this
nurse practitioner intervention.
. Introduction
Patients with coronary heart disease are at high risk for
einfarction and death. Secondary prevention entailing
trategies aimed at decreasing these risks in patients with
stablished coronary heart disease has been shown
ffective in achieving its goal. In Canada and the United
tates, risk factor control outperformed improvements in
edical and surgical treatments as the source of the
ecline in age-adjusted mortality associated with coronary
eart disease over the past two decades (Ford et al., 2007;
ijeysundera et al., 2010). In spite of conclusive evidence
at secondary prevention strategies signiﬁcantly reduce
orbidity and mortality in coronary heart disease
urvivors, a signiﬁcant proportion of patients in whom
ese therapies are indicated are not receiving secondary
revention strategies, or are receiving them in suboptimal
oses (Anderson et al., 2007; Jackevicius et al., 2008;
otseva et al., 2009; Lee et al., 2008; Smith et al., 2011;
usuf et al., 2011).
Based on our ageing population and the growing need
 reduce cardiovascular risks internationally, innovative
ays to improve the uptake and implementation of
econdary prevention strategies are required. In this study,
e nurse practitioner, whose nursing background is
trengthened through advanced training in health assess-
ent, diagnosis, treatment and counselling, is proposed as
n ideal healthcare provider for delivering preventive care
r patients with coronary heart disease.
. Background
Coronary heart disease is a leading cause of death in
anada, the United States, and Europe, and the most
ommon cause of death worldwide reported by the World
ealth Organization (Kochanek et al., 2011; Mathers et al.,
009; Statistics Canada, 2008). Acute myocardial infarction
 an acute presentation of coronary heart disease, which
plays a central role in assessing the burden of heart disease
(Roger, 2007). Despite the dramatic fall in coronary heart
disease mortality rates over the last three decades (Cooper
et al., 2000; Every et al., 2000), the burden of coronary
heart disease and acute myocardial infarction has been
increasing, and is projected to continue to do so into the
next century due to the ageing population. The decline in
coronary heart disease related mortality is thought to be
largely due to improvements in treatment and secondary
prevention (Lenfant, 2003; Roger, 2007).
Secondary prevention incorporates identifying, treat-
ing, and rehabilitating patients with coronary heart
disease or acute myocardial infarction to reduce their
risk of recurrence, decrease their need for interventional
procedures such as coronary artery bypass surgery,
improve quality of life, and extend overall survival
(Cooper et al., 2000). Secondary prevention strategies
include smoking cessation, blood pressure control, lipid
management, physical activity promotion, weight man-
agement, diabetes management, antiplatelet agent/anti-
coagulant use, and long-term use of angiotensin-
converting enzyme inhibitors and beta-adrenoceptor
blockers (Antman et al., 2008; Graham et al., 2007; Smith
et al., 2011). These risk reduction strategies are based on
compelling evidence from clinical trials and are the
foundation for the American Heart Association/American
College of Cardiology Foundation guidelines for secondary
prevention reduction therapy for patients with coronary
and other vascular disease (Antman et al., 2008; Smith et
al., 2011) and the European guidelines on cardiovascular
disease prevention in clinical practice (Graham et al.,
2007).
Although utilization rates of evidence-based strategies
have improved signiﬁcantly over time, target levels have
not yet been achieved in each category of secondary
prevention strategy. Speciﬁcally, there is still much room
for improvement in the initiation of and adherence to non-
pharmacological therapies, such as smoking cessation,
physical activity and referral to cardiac rehabilitation (Teo
et al., 2013), and the long-term adherence to medications
(Kotseva et al., 2009; Yusuf et al., 2011).
Evidence indicates that structured secondary preven-
tion programmes, with and without exercise components,
signiﬁcantly improve outcomes in patients with coronary
heart disease (Clark et al., 2005; McAlister et al., 2001b).
Secondary prevention cardiac programmes which are
exercise-based are widely available in most urban and
suburban communities, but are utilized by less than 20–
30% of the patients who are eligible (Gravely-Witte et al.,
2010; Suaya et al., 2007). In a recent synthesis of the
literature examining strategies to increase patient enrol-
ment in cardiac rehabilitation, Grace et al. (2011)
reported that on average only 34% of those eligible are
referred to cardiac rehabilitation. Similar rates of referral
have been reported in a multinational survey conducted in
15 countries in Europe (Kotseva et al., 2004). In most, if
not all, studies nurses were the most frequently reported
professionals to lead or manage the programmes.
To date, the level of training that nurses possess in
secondary prevention practice settings is not well deﬁned.
However, the level of training that the nurse possesses
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es, both pharmacological and non-pharmacological, can
 implemented in settings where a physician is not
mediately available. For example, clinical settings that
 not have a provider with the authority to titrate
edications to target levels, order smoking cessation
armacotherapy, make referrals to cardiac rehabilitation,
 order diagnostic tests (such as cholesterol levels, liver
nction and renal function tests necessary in monitoring
ogress and response to secondary prevention medica-
ns) will be limited to exercise supervision, education
d counselling, and thereby miss the opportunity for
livering comprehensive secondary prevention in one
tting, at the most opportune time.
Nurse practitioners who participate in expanded
nical practice, including some prescriptive, diagnostic
d treatment authority, are potentially well suited to
liver comprehensive secondary prevention, as their
sponsibilities can span the traditional medical and
rsing domains of practice described in these pro-
ammes. For example, nurse practitioners in many
untries have the authority to diagnose and treat
perlipidemia, hypertension and angina; and can refer
tients to cardiac rehabilitation and psychiatric services
 most jurisdictions. Nurse practitioners are described as
ving the advanced knowledge and skills to deliver
mprehensive preventive care, which includes assess-
ent, diagnosis and treatment of chronic diseases
anadian Nurses Association, 2010; Royal College of
rsing, 2012; Thomas et al., 2012).
Although the nurse practitioner role has not been
eciﬁcally evaluated in secondary prevention, results of
any studies have demonstrated improvements in
tcomes (patient health, quality of life, coordination
d continuity of care, use of health services, access
es, wait times, patient and family satisfaction with
re and health care costs) when advanced practice
rsing roles that include nurse practitioners comple-
ent existing care provider roles and are designed to
dress gaps in the delivery of health care services
redin et al., 1999; Brooten et al., 2002) or focus on
ronic disease management (Litaker et al., 2003;
huttelaar et al., 2010). Evidence shows that: (1) nurse
actitioners are more effective than physicians in areas
lated to patient compliance with treatment recom-
endations (Horrocks et al., 2002); (2) nurse practition-
-run lipid management programmes have been
sociated with signiﬁcant reductions in low density
oprotein cholesterol levels (Allen et al., 2002; DeBusk
 al., 1994; Mason, 2005); (3) transitional care provided
 advanced practice nurses improves outcomes such as
admission rates in cardiac patients (Naylor et al.,
04); (4) nurse practitioners contributed to high quality
ronic disease management (Russell et al., 2009); and
) nurse-led secondary prevention clinics have been
own to improve adherence to secondary prevention
rategies when compared to usual care (Murchie et al.,
03). The role of nurse practitioners in the implemen-
tion of secondary prevention post acute myocardial
farction and their success in achieving beneﬁcial
tcomes have not been investigated.
3. The Study
3.1. Aims
The purpose of this study was to evaluate the effects of
nurse practitioner care on the rate of provider implemen-
tation and patient achievement of evidence-based second-
ary prevention target goals.
3.2. Conceptual framework
The conceptual framework that guided the study was
adapted from a framework developed by Sidani and Irvine
(1999). These authors identiﬁed several factors that
inﬂuence the nurse practitioners’ delivery of care and
subsequent patient outcomes, as well as the key elements
of nurse practitioner practices or processes of care
associated with the expected outcomes.
The adaptation of the framework involved identifying
structure, process, and outcome variables that were most
relevant to the evaluation of the nurse practitioners
contribution in secondary prevention (Fig. 1). Of the
structure variables listed in Fig. 1, only patient character-
istics were assessed and controlled for statistically in this
study. The nurse practitioner professional qualities and
organizational variables were excluded because the
secondary prevention nurse practitioner intervention
was delivered by one nurse practitioner in one setting.
The processes of care were operationalized with the
activities of which the nurse practitioner’s intervention
was comprised and with the practice patterns in which the
nurse practitioner engaged to facilitate delivery of
secondary prevention. The nurse practitioner activities
involve the implementation of secondary prevention
strategies recommended by the American Heart Associa-
tion/American College of Cardiology Foundation and
European guidelines on cardiovascular disease prevention
(Antman et al., 2008; Graham et al., 2007; Smith et al.,
2011). The outcome variables represented the treatment
goals achieved by the patient and expected as a result of
the secondary prevention strategies implemented by the
nurse practitioner.
3.3. Methodology
A prospective cohort design was used to address the
study purpose. Fig. 2 presents a ﬂow diagram of the study
design. A group of patients with acute myocardial
infarction receiving nurse practitioner care was compared
to a group of acute myocardial infarction patients not
receiving nurse practitioner care. All patients admitted to
the coronary care unit over the study period at the selected
setting were screened for eligibility, using the same
inclusion and exclusion criteria. Group allocation was
determined by the composition of the healthcare team to
which patients were assigned upon admission to the
cardiac unit. Nurse practitioners in this facility work
Monday through Friday; patients admitted during week-
days formed the intervention group (i.e., exposed to the
nurse practitioner care). The healthcare team for patients
admitted with acute myocardial infarction over the
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dmitted on the weekend comprised the control group
.e., not exposed to the nurse practitioner).
All patients received usual care. Patients in the nurse
ractitioner care group were given the secondary preven-
on intervention. The intervention included comprehen-
ive cardiovascular assessments and education,
ounselling and treatment recommendations related to
eart attack recovery and secondary prevention care. A
etailed description of the intervention follows.
There is no evidence that the two cohorts of patients
iffer on characteristics that could inﬂuence outcomes.
owever, an examination of baseline comparability of the
o cohorts was completed, and variables showing
igniﬁcant between-group differences were controlled
r statistically to minimize their potential confounding
ﬂuence on outcomes.
Data on the ﬁdelity of the intervention implementation
as obtained during each session with individual parti-
ipants through the use of a clinical log completed by the
urse practitioner. Outcome data were collected at
aseline (time 1) and three months after discharge from
ospital (time 5) for both patient groups.
3.4. Setting
The study was conducted in a large tertiary care
community hospital with full cardiac services (coronary
angiography, coronary artery bypass surgery, cardiac
exercise rehabilitation programme). The hospital is within
a multicultural community with a population of 500,000.
The study was conducted over a one year period (2008–
2009).
3.5. Ethical approval
Ethical approval for conducting clinical research was
obtained from the Research Ethics Board at the University
of Toronto and participating hospital. All participants
provided written, informed consent.
3.6. Usual care
Usual care in this facility consisted of services by a team
of cardiologists, registered nurses, and nurse practitioners
(weekdays). Services available for all acute myocardial
infarction patients included nutritional counselling and
Fig. 1. Conceptual framework for evaluating NP care in delivering secondary prevention post AMI.
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ith referral). Usual care included discharge teaching
 registered nurses and access to an outpatient group
aching session on heart attack recovery. The most
sponsible physician and/or a family physician deter-
ined timing of post discharge follow-up appointments.
l participants in the control group received usual care.
. Intervention
The nurse practitioner delivered the secondary preven-
n intervention in inpatient and outpatient settings. A
tient centred approach was utilized by the nurse
actitioner in delivering the intervention, whereby the
tients’ priorities and preferences are a priority and a
erapeutic alliance is sought. The application of this
proach is expected to yield favourable outcomes
cluding increased patient satisfaction with care, sense
 empowerment, adherence to treatment, and improved
ysical functioning and emotional well-being (Hobbs,
09; Hudon et al., 2011). The content of the intervention
as developed using the American Heart Association/
erican College of Cardiology Foundation guidelines for
condary prevention for patients with coronary and
scular disease (Antman et al., 2008; Smith et al.,
11). All risk reduction strategies were included in the
tervention. These were: delivery of or referral to smoking
ssation counselling; initiation or titration of blood
pressure medications if blood pressure not at target goal;
initiation or titration of lipid lowering therapy if lipid levels
not at target goals; delivery of physical activity counselling
or referral to cardiac rehabilitation programme; measure-
ment of weight, body mass index, waist circumference, and
dietary counselling; measurement of blood glucose and
diabetes risk factor counselling for diabetic patients;
initiation of acetylsalicylic acid, if not contraindicated,
and clopidogrel or warfarin if clinically indicated; initia-
tion or titration of angiotensin-converting inhibitors
towards treatment goals unless contraindicated; and
initiation or titration of beta-adrenergic blocking agents
towards treatment goal unless contraindicated. Each
secondary prevention strategy included in the guidelines
that was applicable to an individual patient was addressed
at each visit. The protocol for the NP intervention can be
found in Table 1.
The intervention was delivered in ﬁve sessions at the
following points in time: time 1, prior to discharge from
hospital; time 2, one week following hospital discharge;
time 3, two weeks after discharge from hospital; time 4, six
weeks after discharge, and time 5, three months after
hospital discharge. The intervention was provided by the
nurse practitioner via face-to-face contact prior to discharge
from hospital, a telephone call to the patient one week
following discharge from hospital, and outpatient clinic
appointments with the nurse practitioner at 2 weeks, 6
weeks and 3 months after discharge from hospital.
Fig. 2. Study ﬂow diagram.
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terventions has not been established, the time intervals
ere selected to maximize the potential of reaching
econdary prevention goals during the period of time in
hich the patient is at highest risk for reinfarction and
eath (Anderson et al., 2007; Kornowski et al., 1993). For
xample, a large study using U.S. Medicare data reported
at in the month following acute myocardial infarction,
e likelihood of death is 21 times higher and the risk of
ospitalization is 12 times higher than the general
opulation over the age of 65 (Dharmarajan et al., 2013).
The number of contacts and the amount of time
llotted for each contact were ﬂexible, based on
dividual patient needs, which is a fundamental
haracteristic of patient-centred care (Robinson et al.,
008). One hour was allocated for each participant before
ischarge from hospital, while 30–60 min were allocated
r the outpatient contacts, delivered in an ambulatory
are setting. Repeated contacts were planned to assist
atients in applying the secondary prevention
recommendations and in addressing potential barriers.
The number of contacts was similar to those reported in
other studies of secondary prevention (Goessens et al.,
2006; Redfern et al., 2009).
3.8. Sample
The target population consisted of patients admitted
for the medical management of acute myocardial
infarction. The eligibility criteria were: conﬁrmed diag-
nosis of acute myocardial infarction (2 out of 3 criteria:
presence of troponin/creatine kinase, chest
pain > 30 min; electrocardiogram changes consistent
with myocardial infarction), and scheduled for discharge
from the cardiac care unit. Patients with a previous
myocardial infarction were included and pertinent data
recorded. Exclusion criteria were: acute myocardial
infarction patients with coronary artery bypass graft
surgery on target admission or those transferred from
another hospital for the purpose of coronary procedures
able 1
urse practitioner intervention protocol.
Nurse practitioner intervention protocol T1: pre-discharge T2: telephone
contact one
week post
discharge
T3: clinic visit
two weeks
post discharge
T4: clinic visit
six weeks post
discharge
T5: outpatient
clinic visit
three months
post discharge
Clinical history and assessment U U U U
Focused CV assessment U U U U
Counselling and guidance on Reinforce
pre-discharge
counselling
and education
Risk factors:
Smoking U U U U
BP U U U U
Lipid U U U U
Physical activity U U U U
Weight U U U U
Diabetes U U U U
Antiplatelet U U U U
B-blocker U U U U
ACE-inhibitor U U U U
Review of signs and symptoms to
report (nitroglycerin use review)
U U U U U
Antiplatelet U U U U U
B-blocker U U U U U
ACE-inhibitor adjustment(s) to target
goal (in consultation with
most responsible physician as needed)
U U U U U
Lipid measurement Obtain baseline
measures from
health record or
arrange with
most responsible
physician
U U U
BP measurement U U U
HbA1c U U
Weight/BMI calculation U U U
Waist circumference U
Liver function and renal function tests
(for monitoring lipid and/or
ACE medications)
U U
Referral to cardiac rehabilitation U U Check on
enrolment
Check on
enrolment
Referral for smoking cessation U U Check on
enrolment
Check on
enrolment
Referral for dietary counselling U U
Schedule outpatient clinic appointments U U U
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orbidity which was expected to effect one year survival
e., metastatic cancer, end stage heart or renal disease)
 reported in the patients’ health record; language
rrier, dementia or cognitive impairment which would
fect ability to understand instructions regarding
atment recommendations, or ability to read and sign
nsent; and geographic/transportation obstacles which
ould prohibit follow-up appointments.
A sample size of 60 patients was estimated to be
equate to detect moderate to large effect sizes for the
tended outcomes at b = .80 and a = .05 (Cohen, 1992).
oderate to large effect sizes have been reported in studies
at investigated secondary prevention strategies included
 the nurse practitioner intervention, such as guideline-
sed care and nurse case management on lipids, diet and
ercise (e.g., Allen et al., 2002; DeBusk et al., 1994;
essens et al., 2006; Murchie et al., 2003). To account for
 anticipated 10% attrition rate 6 additional participants
 in each group) were recruited, for a total of 66 (33 in
ch group).
. Measures
Data were collected on the following variables:
.1. Patient characteristics
Data on patient age, gender, marital status, employ-
ent status, living arrangements, complications of acute
yocardial infarction (heart failure, unstable angina),
edical history (diabetes, hypertension, hyperlipidemia,
ior acute myocardial infarction, congestive heart
ilure, previous coronary artery bypass grafting surgery,
rcutaneous coronary intervention, and stroke), and
oking status were obtained from participants’ medical
cords.
.2. Secondary prevention strategies
To evaluate the ﬁdelity of the intervention, implemen-
tion of secondary prevention strategies by the nurse
actitioner was assessed using a clinical log completed by
e nurse practitioner during each contact with each
rticipant. The nurse practitioner recorded on the clinical
g whether or not she carried out each secondary
evention strategy (listed in intervention section).
.3. Outcomes
The outcome variables included treatment goals
hieved by the patient. These were: smoking status;
stolic blood pressure (mmHg), diastolic blood pressure
mHg); low density lipoprotein cholesterol (mmol/L),
gh density lipoprotein cholesterol (mmol/L), triglycer-
es (mmol/L); involvement in physical activity; atten-
nce at cardiac rehabilitation programme; glycated
emoglobin; and current use of acetylsalicylic acid,
ta-adrenergic blocking agent and angiotensin-convert-
g inhibitor as recommended. For each patient contact, a
ta collection tool was used to record whether or not the
rget goal for each secondary prevention strategy was
hieved based on information available in his/her medical
cord.
3.9.4. Feasibility and acceptability of the nurse practitioner-
delivered intervention
Feasibility was evaluated with the rate at which the
nurse practitioner implemented the secondary prevention
strategies. Acceptability of the intervention was inferred
from the rates of participants’ enrolment and attrition.
3.10. Statistical analysis
Descriptive statistics (frequency distributions, mea-
sures of central tendency and dispersion) were used to
describe the baseline characteristics of the sample, out-
comes measured at each time point, and to test for the
assumption of normality underlying the planned statistical
tests used for data analysis. Independent-samples t-tests
(for continuous variables) and chi-square tests (for
dichotomous variables) were conducted to examine the
comparability of the intervention and control groups on all
baseline variables. The Levene’s test examined the equality
of variance assumption, and if not met, the appropriate
formula for the t-test was reported.
Rates of nurse practitioner implementation of evi-
dence-based secondary prevention strategies were ana-
lyzed descriptively to describe the percentage of
participants who achieved treatment goals.
Analysis of covariance was conducted to compare the
intervention and control groups on post-test outcomes
while controlling for confounding variables. The covariates
included variables showing signiﬁcant between-group
differences at baseline and correlation with the post-test
outcomes, as recommended by Norman and Streiner
(2008). Outcome data were analyzed by use of an
intention-to-treat analysis on the basis of all selected
patients. Data for all patients lost to follow-up or those
who dropped out of the NP care group were analyzed in the
groups to which they were originally assigned.
A multiple regression or logistic regression analysis,
based on the level of measurement of the dependent
variable, was used to examine the outcome variables while
controlling for the same confounding variables included in
the analysis of covariance. For each dependent variable, the
ﬁrst set of predictors included the demographic and
clinical variables showing baseline differences between
groups (age and marital status). The second set consisted of
the number of family physician visits since discharge from
hospital, the number of cardiologist visits since discharge,
and attendance at a cardiac rehabilitation programme.
These variables were included to control for their potential
inﬂuence on outcomes. The third set of predictors was the
group to which participants were assigned (intervention or
control). Lastly, for the intervention group, the number of
contacts and total time spent with the nurse practitioner
were examined as predictors of outcome achievement.
4. Results
4.1. Enrolment and attrition
Of the 75 eligible patients, 65 enrolled and10 refused,
yielding an 87% participation rate. Reasons for non-
enrolment were: admission and discharge timing restricting
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P. Harbman / International Journal of Nursing Studies 51 (2014) 1542–1556 1549urse practitioner participation on the healthcare team,
urgical intervention (such as coronary artery bypass
urgery or valve replacement), and being too ill (ascertained
ith a Charlson Comorbidity Index score greater than 2, as
ocumented in the patient’s chart) (Hall et al., 2005).
The number of participants in the intervention (n = 32)
nd the control (n = 33) group was comparable. A total
umber of 4 participants dropped out, yielding an attrition
ate of 6.1%; 3 were assigned to the control group (9%
ttrition rate for this group) and 1 was assigned to the
tervention group (3% attrition rate for this group). All
ithdrawals occurred after the ﬁrst contact.
.2. Characteristics of participants
The mean age of participants was 58 years. The majority
f participants were men (83%), married (75%), employed
1%), with high school education or above (65%). As
hown in Table 2, the intervention and control groups
ere similar in gender, employment and education. The
ean age of participants in the intervention group was
igniﬁcantly higher than the control group. More partici-
ants in the control group were married, whereas more
articipants in the intervention group were widowed.
herefore, age and marital status were controlled for in the
nalyses comparing the post-test outcomes.
In the total sample, the mean number of days in hospital
as 4.7. Smoking at baseline was reported by 42% of
articipants. Participants had a history of hypertension
2.3%), hyperlipidemia (56.9%), diabetes (24.6%) and
family history of cardiovascular disease (60%). Most had
percutaneous transluminal coronary angioplasty and
stent, with just over one-third (37%) receiving drug-
eluting stent. Only two participants experienced compli-
cations (Table 3). The rates of interventional treatment of
percutaneous angioplasty and use of stents were different
between groups. The variable stent was signiﬁcantly
correlated with age; however it is not known to have
clinically meaningful association with the outcome vari-
ables; therefore it was not controlled for in subsequent
analyses. Similarly, there were no statistically signiﬁcant
between-group differences in the outcomes measured at
baseline (Table 4).
In the total sample, the mean number of family
physician visits during the time period between discharge
from hospital and the three-month follow-up study visit
was 2.51. The mean number of visits to a cardiologist for
the total sample was one visit (range = 0–2). Participants in
the control group (mean = 1.14) visited a cardiologist more
frequently than participants in the intervention group
(mean = .81), p = .003. There were no signiﬁcant differences
between the two groups on the number of family
physician, nutritionist or diabetic clinic visits in the study
period.
4.3. Implementation of the intervention
The nurse practitioner intervention was delivered in
5–11 contacts, with the majority (74.2%) of the 31 patients
assigned to this group made 5–6 contacts with the nurse
able 2
emographic characteristics.
Characteristic Total sample (n = 65) NP group (n = 32) Control group (n = 33) P-value
Mean age (SD) 58.3 (9.87) 61.87 (10.88) 54.9 (7.44) .004
Male, n (%) 54 (83.1) 25 (78.1) 29 (87.9) .29
Married, n (%) 49 (75) 20 (62.5) 29 (87.9) .02
Employed, n (%) 40 (61.5) 17 (53.1) 23 (69.7) .20
Education, n (%) high school 16 (24.6) 8 (25) 8 (24.2) .17
Education, n (%) post secondary 26 (40) 11 (34) 15 (45.45) .17
able 3
linical characteristics.
Characteristic Total sample (n = 65) NP group (n = 32) Control group (n = 33) P-value
Days in hospital, mean (SD) 4.7 (3.96) 5.0 (5.47) 4.48 (1.46) .60
Risk factors, n (%)
Smoker 27 (41.5) 13 (40.6) 14 (42.4) .12
Former smoker 14 (21.5) 10 (31.3) 4 (12.1)
Never smoked 24 (36.9) 9 (28.1) 15 (45.5)
Hypertension 34 (52.3) 18 (56.3) 16 (48.5) .53
Lipids 37 (56.9) 17 (53.1) 20 (60.6) .54
Diabetes 16 (24.6) 8 (25.0) 8 (24.2) .94
Family history 35 (60) 16 (50) 19 (57.6) .54
Prior MI, n (%) 8 (12.3) 5 (15.6) 3 (9.1) .42
PTCA, n (%) 58 (89.2) 26 (81.3) 32 (97) .03
Stent, n (%) 58 (89.2) 26 (81.3) 32 (97) .03
DES, n (%) 24 (36.9) 7 (21.9) 17 (51.5) .01
Troponin, mean (SD) 38.50 (38.42) 33.37 (39.52) 43.46 (37.23) .29
Complications, n (%)
CHF 2 (3.1) 1 (3.1) 1 (3.0) .98
Unstable angina 2 (3.1) 1 (3.1) 1 (3.0) .98ote: MI = myocardial infarction; PTCA = percutaneous transluminal coronary angioplasty; DES = drug eluting stent; CHF = congestive heart failure.
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P. Harbman / International Journal of Nursing Studies 51 (2014) 1542–15561550actitioner, and about a fourth (25.8%) had 7–11 contacts.
e mean number of minutes the NP spent with each
rticipant across all visits was 3.64 h (SD 31.00 min), with
range of 2.67–4.75 h. The number of contacts and the
ount of time the NP spent with patients were not
niﬁcantly associated with successful achievement of
easured outcomes.
Smoking cessation counselling was provided to 92% of
e intervention group participants who were current
okers at baseline (n = 12). Referral and attendance to a
oking cessation clinic occurred in 25% (n = 3) of smokers
 the intervention group. All participants in the interven-
n group who were smokers were offered smoking
ssation clinic referral before discharge from hospital.
Rates of referral to cardiac rehabilitation were 81% in
e intervention group, the remainder declined referral.
Physical activity counselling and measurement of
eight and body mass index calculation were done for
0% of participants. Diabetic teaching was completed
ith all participants, and 100% of participants with
abetes had a glycated haemoglobin measured.
. Effects of the intervention
The intervention and control groups were compared to
amine differences in outcome achievements for each
secondary prevention goal at the three month follow-up
visit, assessed by a research assistant (Table 5). Results of
the analysis of covariance indicated signiﬁcant between-
group differences in triglyceride level and on weeks to
cardiac rehabilitation. The intervention group had lower
triglyceride levels and had a shorter number of weeks from
hospital discharge to cardiac rehabilitation intake than the
control group.
In Table 6, the percentages of achievement for the
dichotomous outcome variables are presented. A larger
percent of participants in the intervention than control
group achieved the following targets: physical activity for
30 min greater than 5 days a week, glycated
haemoglobin < 7 for those with diabetes, and statin use
at 3-month follow-up.
Results of the multiple regression analysis showed that
group membership did not signiﬁcantly predict outcomes
measured at the continuous level. Findings of the logistic
regression indicated that intervention group membership
was a signiﬁcant predictor of smoking cessation, achieve-
ment of blood pressure less than 130/80 mmHg, achieving
the minimum physical activity goal of 5 days a week,
engagement in 30 min of physical activity more than ﬁve
days a week, attendance at cardiac rehabilitation, and
achievement of a glycated haemoglobin level less than 7%
in patients with diabetes (Table 7).
ble 4
tcome variables at baseline.
ariable Total sample (n = 65) NP group (n = 32) Control group (n = 33) P-value
edications on admission, n (%)
ASA 18 (27.7) 7 (21.9) 11 (33.3) .30
Plavix 4 (6.2) 3 (9.4) 1 (3.0) .35
Statin 23 (35.4) 14 (43.8) 9 (27.3) .16
b-blocker 11 (16.9) 8 (25.0) 3 (9.1) .08
ACE inhibitor 15 (23.1) 8 (25.0) 7 (21.2) .71
ARB 5 (7.7) 4 (12.5) 1 (3) .18
DL-C on admission, mean (SD)a 2.44 (1.39) 2.46 (1.76) 2.42 (.88) .91
DL-C, mean (SD)a .94 (.27) .98 (.31) .89 (.21 .18
riglycerides, mean (SD)a 1.75 (1.10) 1.50 (.77) 1.99 (1.33) .08
lood glucose in hospital, mean (SD) b 6.19 (2.39) 5.8 (1.25) 6.59 (3.11) .18
BP prior to discharge, mean (SD)c 116 (13.59) 115.96 (14.52) 114.96 (11.51) .78
BP prior to discharge, mean (SD)c 68.30 (9.71) 66.76 (8.92) 68.11 (9.07) .59
MI, mean (SD)d 27.86 (4.5) 26.4 (4.95) 29.0 (3.85) .07
aist, mean (SD)d 40.56 (4.27) 39.78 (4.23) 41.05 (4.32) .41
te: LDL-C = low density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; SBP = systolic blood pressure; DBP = diastolic blood
ssure; BMI = body mass index.
Measured within 24 h of admission (fasting).
Measured at least 24 h after admission.
Last recorded BP prior to discharge, some unavailable (NP group, n = 5; Control group n = 6).
Baseline BMI unavailable on 12 in NP group, 8 in control group; waist unavailable on 19 in NP group, 13 in control group.
ble 5
hievement of secondary prevention goals at 3-month follow-up, continuous variables, controlling for covariates (adjusted means/SE).
ariable Total (n = 65) NP group (n = 32) Control group (n = 33) F(df) P-value
BP 60 114.11 (2.31) 116.50 (2.40) .47 (56) .50
BP 60 68.12 (1.52) 70.28 (1.58) 0.86 (56) .35
DL-C 59 1.70 (0.10) 1.52 (0.10) 1.34 (55) .25
DL-C 60 0.98 (0.06) 1.08 (0.06) 1.15 (56) .29
riglycerides 58 1.07 (0.14) 1.61 (0.16) 5.48 (54) .02
MI 55 27.47 (0.89) 28.57 (0.95) 0.64 (51) .42
aist 55 39.67 (0.87) 41.91 (0.92) 2.84 (51) .10
eeks to CR 41 8.15 (0.71) 10.50 (0.86) 3.83 (37) .05te: SBP = systolic blood pressure; DBP = diastolic blood pressure; LDL-C = low density lipoprotein cholesterol; HDL-C = high density lipoprotein
olesterol; BMI = body mass index; CR = cardiac rehabilitation.
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.1. Acceptability and feasibility of the intervention
The implementation of the secondary prevention
tervention was considered acceptable, as inferred from
 high participants’ enrolment rate (87%) and low attrition
ate (3%). Lower rates of recruitment were reported in
tudies targeting participants who were completing
ardiac rehabilitation (Lear et al., 2003) and higher rates
 those offering comprehensive lifestyle interventions
elivered by nurses and/or dieticians (Vale et al., 2003;
esthold Heartcare Study Group, 2003). Two other
omparable nurse-led secondary prevention studies have
eported recruitment rates in the 70% range (Campbell
t al., 1998; Goessens et al., 2006).
Attrition rates of 10–18% (Goessens et al., 2006;
ichtman et al., 2004; Masley et al., 2001; Vesthold
eartcare Study Group, 2003) are common in secondary
revention studies, with few reporting less than 10% (Lear
t al., 2003; Redfern et al., 2009). The low attrition rate
bserved in this study could be related to the short follow-
p period. This is consistent with ﬁndings of a systematic
review examining predictors of referral, entry and long-
term behaviour change related to cardiac rehabilitation.
Factors that inﬂuenced each phase of cardiac rehabilitation
differed, indicating that tailoring rehabilitation interven-
tions to individual patients’ preferences and needs would
maximize adherence (Jackson et al., 2005). The high
enrolment and low attrition rates in this study suggest
that the nurse practitioner secondary prevention inter-
vention is a desired option, acceptable to patients with
acute myocardial infarction.
5.2. Characteristics of Participants
The proﬁle of participants is comparable to that
reported in two systematic reviews examining the beneﬁts
of cardiac secondary prevention programmes. The results
of the reviews described participants as mid-aged men
(McAlister et al., 2001a,b; Clark et al., 2005). The similarity
of participants’ characteristics across studies supports the
representativeness of this study sample of the target
population deﬁned as acute myocardial infarction survi-
vors. Therefore the study ﬁndings are applicable to middle
age men with acute myocardial infarction.
able 6
chievements of secondary prevention goals, dichotomous variables.
Variable N by group
intervention/control
Intervention group,
n (%)
Control group,
n (%)
Likelihood
Ratio
P-value
Smoking cessation 12/13* 7 (58) 3 (23) 3.30 .11
Attended smoking cessation clinic 12/13* 3 (25) 0 4.85 .09
BP < 140/90 31/30 4 (12.9) 5 (16.7) .17 .73
BP < 130/80 31/30 28 (90) 24 (80) 1.31 .30
BP < 130/80 (diabetes) 7/6 5 (71.4) 3 (50) .63 .59
LDL-C < 2.6 31/28 9 (29) 9 (32.1) .07 .79
LDL-C < 1.79 31/28 20 (64.5) 19 (67.9) .07 .78
Physical activity >5 days per week 31/30 21 (67.7) 4 (13.3) 20.02 <0.0
Physical activity 5 days per week 31/30 23 (74.2) 18 (60.0) 1.4 .24
Attended cardiac rehabilitation 32/33 24 (75) 19 (57.6) 2.22 .14
Return to work at 3 month follow-up 16/20 7 (43.8) 14 (70) 2.54 .11
Diabetic management (HbA1C < 7 for diabetics) 7/6 7 (100) 2 (33.3) 8.41 .02
ASA at discharge 32/33 32 (100) 31 (93.9) 2.77 .49
ASA at 3 month follow-up 31/30 30 (96.8) 29 (96.7) .001 1.00
Clopidogrel at discharge 32/33 31 (96.9) 32 (97) .00 1.00
Clopidogrel at follow-up 31/30 28 (90.3) 27(90.0) .002 1.0
Statin at discharge 32/33 31 (96.9) 31 (93.9) .324 1.0
Statin at 3 month follow-up 31/30 31 (100) 26 (86.7) 5.97 .05
B-blocker at discharge 32/31 28 (87.5) 28 (84.8) .10 1.0
B-blocker at follow-up 31/30 27 (87.1) 25 (83.3) .17 .73
ACE inhibitor at discharge 32/33 27 (84.4) 28 (84.8) .003 1.0
ACE inhibitor at follow-up 31/30 28 (90.3) 25 (83.3) .66 .47
ote: BP = blood pressure; LDL-C = low-density lipoprotein cholesterol; HbA1C = glycosylated haemoglobin; ASA = aspirin; b-blocker = beta blocker; ACE
hibitor = angiotensin- converting enzyme inhibitor.
* Current smokers at baseline n = 27 (data on 2 participant drop outs missing).
able 7
egression analysis: predictors of outcome achievement.
Variable Exp (B) odds ratio 95% CI for low Odds ratio high
Smoking cessation 4.84 .98 23.88
BP < 130/80 14.78 1.19 183.50
Physical activity > 5 days a week 34.33 5.51 213.97
Physical activity 5 days a week 17.05 1.82 159.68
Attendance at cardiac rehabilitation 7.43 1.61 34.22
HbA1C < 7% with diabetes 9.63 1.83 50.47
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In the context of the current study, the nurse
actitioner spent a longer time (mean 36 min) with the
tient at each visit as compared to the time spent by
ysicians reported in the literature and observed in
nical practice (Ogden et al., 2004). Accordingly, the
rse practitioner had ample opportunity to provide,
rify, and reinforce information about secondary pre-
ntion. This ﬁnding supports the use of appointment
es that exceed the 10-min usually allotted for each
tient, for delivering the nurse practitioner secondary
evention intervention with ﬁdelity.
There is evidence that improvement in implementation
d adherence to clinical practice guidelines by healthcare
ofessionals caring for patients with acute myocardial
farction population are associated with lower mortality
tes. Quality indicators have been developed to measure
herence to key clinical practice guidelines (Tu et al.,
08). The target benchmark for these quality indicators is
% in ideal patients, that is, patients without contra-
dications to treatment recommendation (e.g., allergy to
A) (Tu et al., 2008). These quality indicators serve as a
nchmark and a means for quality improvement.
The nurse practitioner’s implementation of guideline-
sed secondary prevention strategies exceeded 90%
ssessed by a research assistant 3 months post acute
yocardial infarction) for: smoking cessation counselling,
ysical activity counselling, measurement of weight and
dy mass index, dietary counselling, diabetic teaching,
easurement of glycated haemoglobin in patients with
abetes, and medication prescribed at discharge and three
onth follow-up. Only two secondary prevention strategy
tegories were below the ideal target: cardiac rehabilita-
n referral (81%) and angiotensin-converting enzyme
hibitor prescribed at discharge (87%, including 3%
ntraindicated). In the case of the cardiac rehabilitation
ferral rate, 100% of patients were offered referral,
hereas 19% declined. The percentage of those on an
giotensin-converting enzyme inhibitor at discharge was
ghtly under the ideal target, which in the absence of
ntraindications could be related to the nurse practitioner
ving less inﬂuence in an inpatient environment with
ultiple providers, as the 3 month follow-up exceeded
%.
The observed high nurse practitioner performance on
ese quality indicators may be reﬂective of the dedicated
cus of the intervention on secondary prevention, the
ing of the intervention within the patient’s recovery,
e adequacy of the time the nurse practitioner spent
plementing prevention activities, the discharge and
llow-up checklists used by the nurse practitioner, and
e awareness that implementation rates would be
corded and examined in relation to a comparison group.
is is consistent with what is already known about a
riety of methods for increasing adherence to guidelines;
r example, the get with the guidelines programme, the
gest hospital-based national performance initiative for
ronary artery disease (USA), has been successful in
proving guideline adherence in a large number of
spitals. This programme’s stated focus is to improve
adherence to prevention guidelines (Lewis et al., 2008).
Key features of this programme include using a patient
management tool for data collection, clinical decision
support and feedback, as was done in the nurse practition-
er secondary prevention study.
The timing of the nurse practitioner secondary preven-
tion intervention, spanning the period before discharge
and continuing for 3 months, could have contributed to the
high implementation rates for the secondary prevention
strategies. It has been reported that patients are more
motivated to begin and maintain interventions that lower
risks while they are still in hospital (Fonarow and
Ballantyne, 2001). This is likely due to a heightened
awareness of their current health, and strengthened
perception of the link between treatments and the
importance of decreasing future risks (Fonarow and
Ballantyne, 2001).
5.4. Effects of the intervention
The ﬁndings indicated that after three months, acute
myocardial infarction patients who received the secondary
prevention intervention delivered by a nurse practitioner
demonstrated signiﬁcant improvements in multiple treat-
ment goals when compared to patients who received usual
care. The improvements related to the achievement of
lower triglyceride levels, glycated haemoglobin blood
measurements <7% in those with diabetes, smoking
cessation, achieving a blood pressure < 130/80, attending
cardiac rehabilitation, having shorter number of weeks
from hospital discharge to cardiac rehabilitation intake,
achieving the minimum physical activity goal of 5 days a
week, engagement in 30 min of physical activity more than
ﬁve days a week, and remaining on statin medications
three months after discharge from hospital. Overall, the
nurse practitioner’s implementation of the evidence-based
secondary prevention treatment strategies with high
ﬁdelity may have contributed to the clinically relevant
improvements in treatment goals.
The potential impact of this magnitude of improvement
in these risk factors is clinically important. A nurse
practitioner led secondary prevention intervention guided
by well-established guidelines is easy to administer and
effective in decreasing cardiovascular risk. Improvement of
secondary prevention goals, such as those seen in the
intervention group, are known to be associated with
improved outcomes in patients with acute myocardial
infarction. Every percentage increase in guideline adher-
ence has the potential of an equivalent decrease in death
(Peterson et al., 2006). In addition to improvements in
most treatment goals, the intervention was strongly
associated with improvements in risk factors that have
been particularly challenging to improve in other second-
ary prevention programmes: physical activity and diabe-
tes. Diabetes and obesity have recently been identiﬁed as
the last two risk factors cutting into the survival gains
made from declines in smoking, hyperlipidemia and
hypertension (Wijeysundera et al., 2010)
In contrast to ﬁndings on nurse dose reported in
previous studies examining advanced practice nurses
(Brooten et al., 2002), the amount of time or number of
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P. Harbman / International Journal of Nursing Studies 51 (2014) 1542–1556 1553ontacts the NP spent with patients in this study were not
ssociated with successful achievement of outcomes. This
ay be related to both the type of outcomes measured and
e difference in the operationalization of dose. In this
tudy, the number and duration of contacts with the nurse
ractitioner were responsive to individual patients’ needs.
uture research should investigate the appropriateness of
ifferent ways to quantify nurse practitioner dose.
The results of this study are consistent with evidence
at short-term secondary prevention programmes can be
ffective in improving multiple cardiovascular risk factors
nd uptake of guideline based recommendations for
atients with established cardiovascular disease (Clark
t al., 2005). The CHOICE (Choice of Health Options In
revention of Cardiovascular Events) randomized con-
olled trial evaluated a 3-month secondary prevention
tervention for acute coronary syndrome survivors who
ere not accessing cardiac rehabilitation. The intervention
roup had signiﬁcant improvements in the risk factor
vels for total cholesterol, blood pressure, physical
ctivity, smoking cessation and statin use at 3 months,
imilar to those observed in the nurse practitioner
econdary prevention study. However, the Choice of
ealth Options In prevention of Cardiovascular Events
tudy did not specify who delivered the intervention;
ather, the intervention was described as an individual-
ed, structured case management approach overseen by
eating physicians (Redfern et al., 2009), which was
omparable to the approach the nurse practitioner
llowed in delivering the secondary prevention strategies.
hese ﬁndings suggest that an individualized short-term
pproach to secondary prevention, which does not include
 structured exercise component, may have comparable
esults to standard cardiac rehabilitation.
The choice of health options in prevention of cardio-
ascular events study ﬁndings also highlight what is well
nown about cardiac rehabilitation, that the majority of
ligible patients do not access these programmes, and that
ose who opt out may have greater need for risk factor
odiﬁcation and support (e.g., more risk factors, higher
ean levels of low density lipoprotein, more depression
nd lower physical activity in those opting out) (Redfern et
l., 2009).
In the nurse practitioner study, the mean length of time
om hospital discharge to cardiac rehabilitation pro-
ramme participation was 9 weeks (SD 3.30), with the
urse practitioner secondary prevention intervention
eginning before discharge from hospital. This highlights
gain that secondary prevention programmes, with and
ithout exercise components, are effective in improving
isk factor proﬁles in patients with acute myocardial
farction and established cardiovascular disease (Clark
t al., 2005; McAlister et al., 2001a,b), with timing of the
tart of a programme as an additional factor to be
onsidered. Given that the majority of eligible patients
o not attend structured cardiac rehabilitation pro-
rammes, and those who do, start in the range of 6–12
eeks after the event, secondary prevention programmes
utside of traditional cardiac rehabilitation, beginning as
arly as possible, such as done in the nurse practitioner
tudy, appears to be a feasible and effective alternative.
Secondary prevention programmes may be a desired
option for patients who do not have immediate access
to a cardiac rehabilitation programme and may serve to
motivate patients and/or facilitate their engagement in
cardiac rehabilitation programmes.
5.5. Strengths and limitations
The strengths of this study are related to its design and
implementation, which were guided by a clear conceptual
framework. The use of a prospective cohort design with the
application of the same eligibility criteria for selecting
consecutive acute myocardial infarction patients contrib-
uted to comparability between groups on most baseline
characteristics. Variables showing differences at baseline
and signiﬁcant correlation with post-test outcomes were
controlled for statistically. The nurse practitioner inter-
vention was carefully designed to integrate clearly deﬁned
nurse practitioner activities, derived from the nurse
practitioner scope of practice and previous research,
relative to the most recent and effective secondary
prevention strategies. The intervention activities were
operationalized in a log that guided its appropriate
delivery and accurate documentation of the activities
carried out with each participant. This resulted in high
ﬁdelity and standardization of the intervention implemen-
tation and contributed to the achievement of intended
outcomes. The intervention was delivered by one inter-
ventionist to a small sample, in one setting. Single centre
studies, as well as a limited number of interventionists
provide less heterogeneity in the delivery of the interven-
tion and less chance of undetected co-interventions (e.g.,
multiple hospitals would have varying discharge or cardiac
follow-up practices). Homogeneity in treatment delivery
and patient characteristics limits external validity or
applicability of the ﬁndings to other contexts. The
intervention was implemented by one nurse practitioner.
The nurse practitioner may have professional qualities and
an interactional style that may not be reﬂective of those
characterizing other nurse practitioners.
This study involved a small number of patients,
characterized as middle-aged, married, employed men.
Although representative of the patient population served
in the setting and of the acute myocardial infarction
population taking part in research studies, it may not be
representative of two subgroups of cardiac patients that is,
women and older adults.
The sample size in both groups was powered to detect
moderate to large differences between groups, a conser-
vative target for the purposes of examining the feasibility
and acceptability of the intervention. However, small but
clinically signiﬁcant differences in outcomes between the
intervention and comparison groups likely have gone
undetected. The wide conﬁdence intervals reported in the
regression analysis are related to the small sample size.
The data for this study were collected in 2008 and 2009.
Based on the current guidelines for secondary prevention
of cardiovascular disease the intervention as described and
implemented here is still relevant to current practice
recommendations (Antman et al., 2008; Graham et al.,
2007; Smith et al., 2011).
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The study ﬁndings support the ability of the nurse
actitioner to deliver secondary prevention interventions
ithin the full scope of practice. Future research needs to
clude different nurse practitioners in different contexts
 determine the extent to which the nurse practitioner
d setting characteristics inﬂuence implementation of
e intervention and achievement of outcomes, as
oposed by the conceptual framework that guided the
dy. In settings where nurse practitioner care is being
livered in hospital as usual care, consideration should be
ven for comparing three groups in a future study: usual
patient nurse practitioner care and outpatient usual care
hich does not include a nurse practitioner), inpatient
rse practitioner intervention care and nurse practitioner
tervention outpatient care, and inpatient care and
tpatient care which does not include a nurse practition-
. This would make it possible to make comparisons on
e effects of inpatient and outpatient nurse practitioner
re on outcomes separately, which would help further
lineate the inﬂuence of setting on ﬁdelity of intervention
plementation and on the measured outcomes.
The cost-effectiveness of this type of nurse practitioner
condary prevention intervention should be investigated
 future research. In addition to replicating this research
ith a larger sample, an examination of the impact of
ancial factors limiting secondary prevention medication
e and entry into cardiac rehabilitation programmes –
cumstances which can be potentially improved with a
rse practitioner intervention would be helpful in fully
derstanding the potential contribution of the nurse
actitioner in this type of practice setting.
This study demonstrates that the nurse practitioner
condary prevention intervention potentially has broad
peal for acute myocardial infarction patients in this type
 practice setting. The high enrolment and low attrition
tes may represent a desire for cardiac follow-up in the
e period extending from hospital stay to three months
st acute myocardial infarction. This study highlights the
tential advantages of providing care that spans the
patient and outpatient settings, with frequent follow-
s at a time when patients’ motivation for change is
ightened. Secondary prevention programmes that in-
rporate pre- and post-discharge secondary prevention
aching, and early outpatient follow-up could serve as a
idge to entry into cardiac rehabilitation.
Additionally, secondary prevention programmes such
 the one studied here may appeal to patients who desire
 alternative to traditional cardiac rehabilitation, or to
ose who could beneﬁt from assistance in overcoming
rriers to cardiac rehabilitation. This could also poten-
lly translate into reaching those who have been shown
 attend cardiac rehabilitation the least (women and the
erly). Further research is needed on programme
eferences, especially for those less likely to attend
ditional cardiac rehabilitation. Providers delivering
condary prevention should build time in their practices
 allow adequate time for health teaching, discussing
atment options, and the opportunity for individual
6. Conclusion
The results of this study demonstrate that a nurse
practitioner can safely and effectively deliver a compre-
hensive secondary prevention intervention. This study
found that a nurse practitioner delivered secondary
prevention intervention is well received by patients and
signiﬁcantly improves the implementation of guideline
based secondary prevention treatments and risk factor
reduction strategies. Every percentage increase in guide-
line adherence has the potential of an equivalent decrease
in death (Peterson et al., 2006). In addition to improve-
ments in most secondary prevention treatment goals, the
nurse practitioner secondary prevention intervention was
strongly associated with improvements in secondary
prevention goals and risk factors that have been particu-
larly challenging to improve in other secondary prevention
programmes: physical activity and diabetes. Interventions
such as this, which successfully address those risk factors,
and multiple others, warrant replication with two or more
nurse practitioners and a larger sample of subjects to
validate the results.
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